Comments
Global pharmaceutical major Strides Arcolab on Tuesday said its Singapore-based wholly owned subsidiary Strides Pharma Global has been awarded ‘International Headquarters Status’ by the Singapore Economic Development Board (EDB).
Strides Pharma Global proposes to carry out activities for its international business, including business development and planning, sales and marketing, intellectual property management, global supply chain management and global regulatory affairs.
“Singapore was selected as the International headquarters after assessing various options. Strides Pharma Global, Singapore will also be building a new manufacturing facility in Singapore in the next couple of years with focus on the regulated and South East Asia markets,” Strides Pharma Global CEO Mohan Kumar said in a statement here.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.